Vasculitis in children and adolescents: Clinical presentation, etiopathogenesis, and treatment

Pediatric Drugs

Volumn 11, Issue 6, 2009, Pages 375-380

  Tullus, Kjell ^a   Marks, Stephen D ^a  

^a Great Ormond Street Hospital for Children NHS Trust ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; DISEASE COURSE; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; CHILD; HUMANS; VASCULITIS;

EID: 70449389836     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11316120-000000000-00000     Document Type: Review

References (37)

1. Dillon MJ. Childhood vasculitis. Lupus 1998; 7 (4): 259-265
2. Lane SE, Watts RA, Shepstone L, et al. Primary systemic vasculitis: clinical features and mortality. QJM 2005 Feb; 98 (2): 97-111
3. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006 Jul; 65 (7): 936-941
4. Jennette JC, Falk RJ,Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994 Feb; 37 (2): 187-192
5. Lie JT. Nomenclature and classification of vasculitis: plus ca change, plus c'est la meme chose. Arthritis Rheum 1994 Feb; 37 (2): 181-186
6. Dillon MJ, Ozen S. A new international classification of childhood vasculitis. Pediatr Nephrol 2006 Sep; 21 (9): 1219-1222
7. Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002 Oct 19; 360 (9341): 1197-1202
8. Burns JC. Commentary: translation of Dr Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J 2002 Nov; 21 (11): 993-995
9. Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.Arch Dis Child 2001; 86: 286-290
10. Brogan PA, Shah V, Clarke LA, et al. T cell activation profiles in Kawasaki syndrome. Clin Exp Immunol 2008 Feb; 151 (2): 267-274
11. Sundel RP, Baker AL, Fulton DR, et al. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 2003 Jun; 142 (6): 611-616
12. Rai A, Nast C, Adler S. Henoch-Schonlein purpura nephritis. J Am Soc Nephrol 1999; 10: 2637-2644
13. Tizard EJ. Henoch-Schonlein purpura. Arch Dis Child 1999; 80: 380-383
14. Brogan PA. What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 2007 Aug; 22 (8): 1083-1094
15. Ronkainen J, Koskimies O, la-Houhala M, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 Aug; 149 (2): 241-247
16. Dillon MJ. Henoch-Schonlein purpura: recent advances. Clin Exp Rheumatol 2007 Jan; 25 (1 Suppl. 44): S66-8
17. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998 Jun; 53 (6): 1755-1759
18. Scharer K, Krmar R, Querfeld U, et al. Clinical outcome of Schonlein- Henoch purpura nephritis in children. Pediatr Nephrol 1999 Nov; 13 (9): 816-823
19. Wright E, Dillon MJ, TullusK. Childhood vasculitis and plasma exchange. Eur J Pediatr 2007 Feb; 166 (2): 145-151
20. Hogg RJ, Fitzgibbons L, Atkins C, et al. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent. Clin J Am Soc Nephrol 2006 Nov; 1 (6): 1167-1172
21. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002; 13: 1953-1960
22. Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr 2004 Aug; 163 (8): 425-434
23. Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 2002 Sep; 17 (9): 754-761
24. Shovman O, Gilburd B, Zandman-Goddard G, et al. Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides. Curr Rheumatol Rep 2006 Aug; 8 (4): 292-298
25. Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin JAmSoc Nephrol 2007Mar; 2 (2): 290-299
26. Stegeman CA, Tervaert JW, Sluiter WJ, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994 Jan; 120 (1): 12-17
27. Ohtake T, Kobayashi S, Honjou Y, et al. Generalized Wegener's granulomatosis responding to sulfamethoxazole-trimethoprim monotherapy. Intern Med 2001 Jul; 40 (7): 666-670
28. Brogan PA, Davies R, Gordon I, et al. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 2002 Apr; 17 (4): 277-283
29. Bakkaloglu A, Ozen S. Wegener's granulomatosis, microscopic polyangiitis and childhood polyarteritis nodosa. In: GearyDF, Schaeffer F, editors. Pediatric nephrology. Philadelphia (PA); Mosby Elsevier, 2008: 353-358
30. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002; 55: 481-486
31. McCulloch M, Andronikou S, Goddard E, et al. Angiographic features of 26 children with Takayasu's arteritis. Pediatr Radiol 2003 Apr; 33 (4): 230-235
32. Millar AJ, Gilbert RD, Brown RA, et al. Abdominal aortic aneurysms in children. J Pediatr Surg 1996 Dec; 31 (12): 1624-1628
33. Marks SD, Sebire NJ, Pilkington C, et al. Clinicopathological correlations of paediatric lupus nephritis. Pediatr Nephrol 2007 Jan; 22 (1): 77-83
34. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004 Feb; 15 (2): 241-250
35. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004 Feb; 65 (2): 521-530
36. Steinlin MI, Blaser SI,Gilday DL, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995 Oct; 13 (3): 191-197
37. Marks SD, Patey S, Brogan PA, et al. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 2005 Oct; 52 (10): 3168-3174